GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Alliqua BioMedical stock price ended at $2.69 on Wednesday, after losing 0%.
(Updated on Sep 18, 2019)

Hold candidate since Sep 17, 2019 PDF

No changes to the price of Alliqua BioMedical stock on the last trading day (Wednesday, 18th Sep 2019). During the last trading day the stock fluctuated 0% from a day low at $2.69 to a day high of $2.69. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Alliqua BioMedical stock with a 90% probability to be traded between $2.02 and $3.30 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALQA Signals & Forecast

There are mixed signals in the stock today. The Alliqua BioMedical stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.69 and $2.72. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, August 09, 2019, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Alliqua BioMedical stock

Alliqua BioMedical finds support from accumulated volume at $2.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $2.53 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 27 days ago.)

Trading Expectations (ALQA) For The Upcoming Trading Day Of Thursday 19th

For the upcoming trading day on Thursday, 19th we expect Alliqua BioMedical to open at $2.69, and during the day (based on 14 day Average True Range), to move between $2.64 and $2.74, which gives a possible trading interval of +/-$0.0469 (+/-1.74%) up or down from last closing price. If Alliqua BioMedical takes out the full calculated possible swing range there will be an estimated 3.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.75 (2.23%) than the support at $2.60 (3.35%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Alliqua BioMedical stock A Buy?

Alliqua BioMedical holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.155 Hold/Accumulate Unchanged

Predicted Opening Price for Alliqua BioMedical of Thursday, September 19, 2019

Fair opening price September 19, 2019 Current price
$2.69 ( 0%) $2.69

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALQA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.69 .
R2 2.69 .
R1 2.69 .
Current price: 2.69
Support S1 2.69 .
S2 2.69 .
S3 2.69 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.00 11.52 %
R2 2.85 5.95 %
R1 2.75 2.23 %
Current price 2.69
Support S1 2.60 -3.35%
S2 2.25 -16.36%
S3 2.02 -24.91%

FAQ

What is the symbol for Alliqua BioMedical Stock and on which exchange is it traded?
The symbol for Alliqua BioMedical is ALQA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alliqua BioMedical Stock?
Alliqua BioMedical holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Alliqua BioMedical Stock?
Alliqua BioMedical Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alliqua BioMedical Stock.

What's the current price of Alliqua BioMedical Stock?
As of the end of day on the 2019-09-18, the price of an Alliqua BioMedical (ALQA) share was $2.69.

What is the 52-week high and low for Alliqua BioMedical Stock?
The 52-week high for Alliqua BioMedical Stock is $10.94 and the 52-week low is $1.55.
Click to get the best stock tips daily for free!

About Alliqua BioMedical

Alliqua BioMedical, Inc. provides wound care solutions in the United States and internationally. The company offers the MIST Therapy system for the treatment of acute and chronic wounds; Extracellular Matrix, a suite of advanced wound management products; Biovance, a decellularized and dehydrated allograft for the management of non-infected partial-and full-thickness wounds; SilverSeal, a hydrogel wound dressing with silver coated fibers; connect... ALQA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT